Zimmer Biomet Holdings Inc
Gesloten
SectorGezondheidszorg
89.97 2.76
Overzicht
Wijziging aandelenprijs
24u
Min
87.54
Max
90.5
Inkomsten | 99M 239M |
|---|---|
Verkoop | -157M 2.1B |
K/W Sectorgemiddelde | 22.797 50.958 |
EPS | 2.09 |
Dividendrendement | 1.1 |
Winstmarge | 11.43 |
Werknemers | 17,000 |
EBITDA | 84M 538M |
Aanbevelingen | Neutraal |
|---|---|
12 Maanden Prognose | +7.02% upside |
Dividendrendement Sectorgemiddelde | 1.10% 2.41% |
|---|---|
Volgende Winsten | 6 aug 2026 |
Volgende dividenddatum | 31 jul 2026 |
Volgende Ex Dividend datum | 25 jun 2026 |
Marktkapitalisatie | -899M 17B |
|---|---|
Vorige openingsprijs | 87.21 |
Vorige sluitingsprijs | 89.97 |
Nieuwssentiment
By Acuity
50%
50%
146 / 342 Rangschikking in Healthcare
Zimmer Biomet Holdings Inc Grafiek
Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.
Over Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, EMEA, and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its other product category primarily includes its robotic, surgical and bone cement products. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and others.